Matica Bio
Matica Bio and VaxDome Partner
to Develop Antigen-Agnostic
Antiviral-Vaccine Hybrids with Influenza
as One of the Disease Models
Matica Biotechnology, Inc. (“Matica Bio”), a viral vector contract development and manufacturing organization (CDMO), is partnering with Texas-based biotech VaxDome Inc. to bring its novel antigen-agnostic antiviral-vaccine hybrid candidates into…
